Minerva Neurosciences
NERV
#9640
Rank
NZ$0.19 B
Marketcap
NZ$4.17
Share price
1.08%
Change (1 day)
-37.54%
Change (1 year)

Market capitalization of Minerva Neurosciences (NERV)

Market cap: NZ$0.19 Billion

As of November 2026 Minerva Neurosciences has a market cap of NZ$0.19 Billion. This makes Minerva Neurosciences the world's 9640th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Minerva Neurosciences from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.19 B-36.41%
2025NZ$0.31 B1017.16%
2024NZ$28.02 M-58.79%
2023NZ$68 M408.54%
2022NZ$13.37 M-73.31%
2021NZ$50.09 M-63.84%
2020NZ$0.13 B-66.42%
2019NZ$0.41 B5.46%
2018NZ$0.39 B18.68%
2017NZ$0.32 B-44.16%
2016NZ$0.59 B169.3%
2015NZ$0.21 B54.75%
2014NZ$0.14 B

End of Day market cap according to different sources

On Nov 2nd, 2026 the market cap of Minerva Neurosciences was reported to be:

NZ$0.19 Billion
by Nasdaq info icon info icon
NZ$0.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Incyte
INCY
NZ$43.50 B 21,752.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
NZ$3.23 B 1,525.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
NZ$20.92 M-89.49%๐Ÿ‡บ๐Ÿ‡ธ USA